share_log

Altimmune | 4: Statement of changes in beneficial ownership of securities-Officer Jordt Raymond M

SEC announcement ·  Aug 1 17:46
Summary by Moomoo AI
Raymond M. Jordt, the Chief Business Officer of Altimmune, Inc., completed a purchase of 917 shares of common stock on July 31, 2024. The transaction was carried out directly with the shares valued at $5.41 each. Following this acquisition, Jordt's total direct holdings in the company increased to 14,660 shares. The transaction is part of a grant, award, or other acquisition, as per the transaction code description provided.
Raymond M. Jordt, the Chief Business Officer of Altimmune, Inc., completed a purchase of 917 shares of common stock on July 31, 2024. The transaction was carried out directly with the shares valued at $5.41 each. Following this acquisition, Jordt's total direct holdings in the company increased to 14,660 shares. The transaction is part of a grant, award, or other acquisition, as per the transaction code description provided.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more